Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-13
DOI
10.1038/s41467-018-04805-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IGF1 Shapes Macrophage Activation in Response to Immunometabolic Challenge
- (2017) Olga Spadaro et al. Cell Reports
- Longevity is impacted by growth hormone action during early postnatal period
- (2017) Liou Y Sun et al. eLife
- IGF-1 has sexually dimorphic, pleiotropic, and time-dependent effects on healthspan, pathology, and lifespan
- (2017) Nicole M. Ashpole et al. GeroScience
- Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer
- (2016) Randy Strong et al. AGING CELL
- Rapamycin transiently induces mitochondrial remodeling to reprogram energy metabolism in old hearts
- (2016) Ying Ann Chiao et al. Aging-US
- The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future Research
- (2016) Sofiya Milman et al. Cell Metabolism
- Sex Differences in Lifespan
- (2016) Steven N. Austad et al. Cell Metabolism
- Deletion of IGF-1 Receptors in Cardiomyocytes Attenuates Cardiac Aging in Male Mice
- (2016) Sangmi Ock et al. ENDOCRINOLOGY
- Disruption of the GH Receptor Gene in Adult Mice Increases Maximal Lifespan in Females
- (2016) Riia K. Junnila et al. ENDOCRINOLOGY
- The somatotropic axis and aging: Benefits of endocrine defects
- (2016) Andrzej Bartke et al. GROWTH HORMONE & IGF RESEARCH
- Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice
- (2016) Alessandro Bitto et al. eLife
- Quality control systems in cardiac aging
- (2015) Ellen K. Quarles et al. AGEING RESEARCH REVIEWS
- Central insulin-like growth factor-1 (IGF-1) restores whole-body insulin action in a model of age-related insulin resistance and IGF-1 decline
- (2015) Derek M. Huffman et al. AGING CELL
- Interventions to Slow Aging in Humans: Are We Ready?
- (2015) Valter D. Longo et al. AGING CELL
- The somatotropic axis and longevity in mice
- (2015) H. M. Brown-Borg AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin
- (2015) Rita Slaaby Scientific Reports
- Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity
- (2014) Sofiya Milman et al. AGING CELL
- Differential impact of selective GH deficiency and endogenous GH excess on insulin-mediated actions in muscle and liver of male mice
- (2014) Jose Cordoba-Chacon et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Long- But Not Short-Term Adult-Onset, Isolated GH Deficiency in Male Mice Leads to Deterioration of β-Cell Function, Which Cannot Be Accounted for by Changes in β-Cell Mass
- (2014) Jose Cordoba-Chacon et al. ENDOCRINOLOGY
- IGF1R blockade with ganitumab results in systemic effects on the GH–IGF axis in mice
- (2014) Gordon Moody et al. JOURNAL OF ENDOCRINOLOGY
- Reductions in serum IGF-1 during aging impair health span
- (2013) Zhenwei Gong et al. AGING CELL
- Longevity effect of IGF-1R+/−mutation depends on genetic background-specific receptor activation
- (2013) Jie Xu et al. AGING CELL
- Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males
- (2013) David E. Harrison et al. AGING CELL
- The adverse events profile of anti-IGF-1R monoclonal antibodies in cancer therapy
- (2013) Honghai Ma et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Abdominal Obesity, Independent from Caloric Intake, Accounts for the Development of Intestinal Tumors in Apc1638N/+ Female Mice
- (2013) D. M. Huffman et al. Cancer Prevention Research
- The GH/IGF-1 axis in ageing and longevity
- (2013) Riia K. Junnila et al. Nature Reviews Endocrinology
- Epitope-Specific Mechanisms of IGF1R Inhibition by Ganitumab
- (2013) Frank J. Calzone et al. PLoS One
- IGF-IR signaling attenuates the age-related decline of diastolic cardiac function
- (2012) Sarah Moellendorf et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors
- (2012) William D. Tap et al. JOURNAL OF CLINICAL ONCOLOGY
- Insulin Resistance and Aging: A Cause or a Protective Response?
- (2012) N. Barzilai et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- The Emerging Role of IGF-1 Deficiency in Cardiovascular Aging: Recent Advances
- (2012) Z. Ungvari et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Impaired IGF1R signaling in cells expressing longevity-associated human IGF1R alleles
- (2011) Cagdas Tazearslan et al. AGING CELL
- Does Reduced IGF-1R Signaling in Igf1r+/− Mice Alter Aging?
- (2011) Alex F. Bokov et al. PLoS One
- Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans
- (2011) J. Guevara-Aguirre et al. Science Translational Medicine
- Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice
- (2010) Jacob A. Panici et al. FASEB JOURNAL
- Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1
- (2009) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Deletion of Astrocyte Connexins 43 and 30 Leads to a Dysmyelinating Phenotype and Hippocampal CA1 Vacuolation
- (2009) S. E. Lutz et al. JOURNAL OF NEUROSCIENCE
- Reduced Incidence and Delayed Occurrence of Fatal Neoplastic Diseases in Growth Hormone Receptor/Binding Protein Knockout Mice
- (2009) Y. Ikeno et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells
- (2009) P. J. Beltran et al. MOLECULAR CANCER THERAPEUTICS
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
- (2009) David E. Harrison et al. NATURE
- Effect of exercise and calorie restriction on biomarkers of aging in mice
- (2008) Derek M. Huffman et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Functionally significant insulin-like growth factor I receptor mutations in centenarians
- (2008) Y. Suh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now